European Autism Interventions - A Multicentre Study for Developing New Medications (EU-AIMS) - is the largest single grant for autism in the world, and the largest for the study of any mental health disorder in Europe.

Projects :

The European Babysibs Autism Research Network (Eurosibs)
Autism Spectrum Disorders in Europe

Founders :

he EU-AIMS project is funded by the Innovative Medicines Initiative (IMI), a large-scale public-private partnership between the European Union and the pharmaceutical industry association EFPIA.


Coordination Team Members

Project Coordinator

Dr. Will Spooren
Group Leader Behavioral Pharmacology
F. Hoffmann-La Roche CNS - DTA Building 72-141
4070 Basel
Switzerland

Managing Entity (academic lead)

Professor Dr. Declan Murphy
King's College London
Department of Forensic and Neurodevelopmental Sciences
PO50 Institute of Psychiatry
DeCrespigny Park
London
SE5 8AF
United Kingdom

Deputy of Coordinator

Dr. Omar Khwaja
Hoffmann-La RocheCNS - DTA
Building 72-141
Basel 4070
Switzerland


Project Science Coordination

Eva Loth

Dr. Eva Loth
Department of Forensic and Neurodevelopmental Sciences
P050, Institute of Psychiatry
King’s College London
De Crespigny Park
Denmark Hill
London SE5 8AF


Project Manager

Dr. Claudia Speiser
GABO:milliarium mbH & Co. KG
Oskar-von-Miller Ring 29
80333 Munich
Germany